DE69636801D1 - Dioxinoderivate und ihre Verwendung als Dopamine Agonisten - Google Patents

Dioxinoderivate und ihre Verwendung als Dopamine Agonisten

Info

Publication number
DE69636801D1
DE69636801D1 DE69636801T DE69636801T DE69636801D1 DE 69636801 D1 DE69636801 D1 DE 69636801D1 DE 69636801 T DE69636801 T DE 69636801T DE 69636801 T DE69636801 T DE 69636801T DE 69636801 D1 DE69636801 D1 DE 69636801D1
Authority
DE
Germany
Prior art keywords
dopamine agonists
dioxin derivatives
dioxin
derivatives
dopamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69636801T
Other languages
English (en)
Other versions
DE69636801T2 (de
Inventor
Gary Paul Stack
Richard Eric Mewshaw
Byron Abel Bravo
Young Hee Kang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of DE69636801D1 publication Critical patent/DE69636801D1/de
Application granted granted Critical
Publication of DE69636801T2 publication Critical patent/DE69636801T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69636801T 1995-11-06 1996-10-22 Dioxinoderivate und ihre Verwendung als Dopamine Agonisten Expired - Lifetime DE69636801T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US730267 1991-07-12
US728395P 1995-11-06 1995-11-06
US7283P 1995-11-06
US08/730,267 US5756532A (en) 1995-11-06 1996-10-15 Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives

Publications (2)

Publication Number Publication Date
DE69636801D1 true DE69636801D1 (de) 2007-02-08
DE69636801T2 DE69636801T2 (de) 2007-04-26

Family

ID=26676776

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636801T Expired - Lifetime DE69636801T2 (de) 1995-11-06 1996-10-22 Dioxinoderivate und ihre Verwendung als Dopamine Agonisten

Country Status (21)

Country Link
US (2) US5756532A (de)
EP (3) EP1375503B1 (de)
JP (1) JP4311770B2 (de)
KR (1) KR100566678B1 (de)
CN (1) CN1084748C (de)
AR (2) AR004284A1 (de)
AT (1) ATE349450T1 (de)
AU (1) AU701624B2 (de)
CA (1) CA2189524C (de)
CZ (1) CZ291731B6 (de)
DE (1) DE69636801T2 (de)
DK (1) DK1375503T3 (de)
ES (1) ES2277014T3 (de)
HU (1) HU224841B1 (de)
IL (1) IL119565A (de)
MX (1) MX9605367A (de)
NO (1) NO317054B1 (de)
NZ (1) NZ299693A (de)
PT (1) PT1375503E (de)
RU (1) RU2178416C2 (de)
SK (1) SK282168B6 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents
GB9704948D0 (en) 1997-03-11 1997-04-30 Knoll Ag Therapeutic agents
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles
US6350773B1 (en) * 1999-12-10 2002-02-26 American Home Products Corporation Therapeutic combinations of (S)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro 7H-1,4-dioxino{2,3-e}indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders
MXPA02005649A (es) 1999-12-10 2004-09-10 Wyeth Corp Nuevas combinaciones terapeuticas de (s)-2 -(bencilamino -metil)-2, 3, 8, 9-tetrahidro-7h -1, 4-dioxino(2-3 -e]indol-8 -ona y agentes neurolepticos para el tratamiento o prevencion de trastornos psicoticos.
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
US20060287335A1 (en) * 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
US6458802B1 (en) 2001-03-14 2002-10-01 Wyeth Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-f]quinoline
US6803368B2 (en) 2001-04-25 2004-10-12 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naphthalene
US6861427B2 (en) * 2001-04-26 2005-03-01 Wyeth Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-HT1A antagonists
US6800648B2 (en) 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-1,6,9-trioxa-3-AZA-cyclopenta[a]naphthalen-2-one
US6800642B2 (en) 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-2,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
US6927226B2 (en) 2001-04-26 2005-08-09 Wyeth Antidepressant azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene
US6861434B2 (en) * 2001-04-26 2005-03-01 Wyeth Antipsychotic aminomethyl derivatives of 1,3,7,8-tetrahydro-6,9-dioxa-1,3-diaza-cyclopenta[a]-naphthalen-2-one
US6821981B2 (en) 2001-04-26 2004-11-23 Wyeth Azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]-quinoline as 5-HT1A antagonists
US6800641B2 (en) 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-2,3-diaza-cyclopenta[a]naphthalene
DE60206048T2 (de) * 2001-04-26 2006-07-13 Wyeth Antidepressive (sssri) azaheterocyclylmethylderivate von 7,8-dihydro-3h-6,9-dioxa-1,3-diazacyclopenta [a] naphthalin
US7008944B2 (en) * 2001-04-26 2006-03-07 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-Dioxino[2,3-f]quinoxaline
ATE334989T1 (de) * 2001-04-26 2006-08-15 Wyeth Corp Antidepressive azaheterocyclylmethyl-derivate von 2,3-dihydro-1,4-dioxino 2,3-föchinoxalin
US6656947B2 (en) 2001-04-26 2003-12-02 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
US6555560B2 (en) * 2001-04-30 2003-04-29 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
US6906206B2 (en) 2001-04-30 2005-06-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
MXPA03010524A (es) * 2001-05-17 2005-03-07 Wyeth Corp Proceso para la sintesis de derivados de la 2,3-dihidro-1,4-dioxino-[2,3-f]-quinolina.
US6541502B1 (en) 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
US6541501B2 (en) 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
US6903110B2 (en) 2001-07-25 2005-06-07 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene
US7135479B2 (en) 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
US6800637B2 (en) * 2002-09-12 2004-10-05 Wyeth Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
US7153849B2 (en) * 2002-09-12 2006-12-26 Wyeth Antidepressant arylpiperazine derivatives of hetrocycle-fused benzodioxans
US6939877B2 (en) * 2002-09-12 2005-09-06 Wyeth Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
CN100352820C (zh) * 2002-09-12 2007-12-05 惠氏公司 抗抑郁的杂环稠合的苯并二噁烷的氮杂环甲基衍生物
CN1874767A (zh) * 2003-10-29 2006-12-06 惠氏公司 包含aplindore和其衍生物的缓释药物组合物
GT200600078A (es) 2005-02-17 2007-04-12 Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquil condensados
JP2008531694A (ja) * 2005-03-01 2008-08-14 ワイス 結晶性および非晶性４−シアノ−ｎ−｛（２ｒ）−２−［４−（２，３−ジヒドロ−ベンゾ［１，４］ジオキシン−５−イル）−ピペラジン−１−イル］−プロピル｝−ｎ−ピリジン−２−イル−ベンズアミド塩酸塩
EP1871355A1 (de) * 2005-04-22 2008-01-02 Wyeth Neue therapeutische kombinationen zur behandlung oder prävention von depression
TW200811182A (en) 2006-05-25 2008-03-01 Wyeth Corp Oxindoledioxans, synthesis thereof, and intermediates thereto
WO2008118935A1 (en) * 2007-03-26 2008-10-02 Neurogen Corporation Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-ones
EA023430B1 (ru) 2009-03-30 2016-06-30 виТиви ТЕРАПЬЮТИКС ЭлЭлСи Замещенные производные азоантрацена, фармацевтические композиции и способы их применения
RU2554885C1 (ru) * 2014-05-27 2015-06-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) Антагонисты пуринорецепторов на основе новых производных пиридоксина
RU2554883C1 (ru) * 2014-05-27 2015-06-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) Применение производных ацеталей пиридоксина в качестве антагонистов пуринорецепторов

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05505599A (ja) * 1990-03-15 1993-08-19 ジ・アップジョン・カンパニー 治療上有用な複素環インドール化合物類
US5126366A (en) * 1991-06-21 1992-06-30 American Home Products Corporation Aminophenoxyalkyl derivatives of benzodioxan
US5189171A (en) * 1991-06-21 1993-02-23 American Home Products Corporation Antipsychotic benzodioxan derivatives
US5166367A (en) * 1991-06-21 1992-11-24 American Home Products Corporation Antipsychotic benzodioxan derivatives
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
US5235055A (en) * 1992-09-02 1993-08-10 American Home Products Corporation Antipsychotic quinoline derivatives of benzodioxanmethylamine
US5245051A (en) * 1992-09-03 1993-09-14 American Home Products Corporation Antipsychotic chroman derivatives of benzodioxanmethylamine

Also Published As

Publication number Publication date
HUP9603057A3 (en) 1998-12-28
HU224841B1 (en) 2006-03-28
MX9605367A (es) 1997-10-31
CN1155546A (zh) 1997-07-30
NO964686D0 (no) 1996-11-05
CA2189524C (en) 2007-05-01
NO317054B1 (no) 2004-08-02
NZ299693A (en) 1997-09-22
US5962465A (en) 1999-10-05
CZ291731B6 (cs) 2003-05-14
CA2189524A1 (en) 1997-05-07
EP0771800A3 (de) 1998-01-28
EP0771800A2 (de) 1997-05-07
AU701624B2 (en) 1999-02-04
ES2277014T3 (es) 2007-07-01
NO964686L (no) 1997-05-07
SK141496A3 (en) 1997-08-06
EP1375503B1 (de) 2006-12-27
EP1726592A1 (de) 2006-11-29
AR025698A1 (es) 2002-12-11
AU7055396A (en) 1997-05-15
IL119565A0 (en) 1997-03-18
RU2178416C2 (ru) 2002-01-20
DE69636801T2 (de) 2007-04-26
IL119565A (en) 2002-11-10
SK282168B6 (sk) 2001-11-06
EP1375503A1 (de) 2004-01-02
JPH09249671A (ja) 1997-09-22
AR004284A1 (es) 1998-11-04
US5756532A (en) 1998-05-26
CN1084748C (zh) 2002-05-15
KR970027068A (ko) 1997-06-24
CZ324196A3 (en) 1997-12-17
JP4311770B2 (ja) 2009-08-12
DK1375503T3 (da) 2007-01-22
HU9603057D0 (en) 1996-12-30
PT1375503E (pt) 2007-03-30
KR100566678B1 (ko) 2006-11-30
HUP9603057A2 (en) 1997-05-28
ATE349450T1 (de) 2007-01-15

Similar Documents

Publication Publication Date Title
DE69636801D1 (de) Dioxinoderivate und ihre Verwendung als Dopamine Agonisten
ATE310739T1 (de) Pyrazol-4-yl-benzoylderivate und ihre verwendung als herbizide
DE59710580D1 (de) Thiocyano-triazolyl-derivate und ihre verwendung als mikrobizide
DE59712887D1 (de) Substituierte phenylketoenole und ihre verwendung als schädlingsbekämpfungsmittel
DE60036803D1 (de) Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
DE69610822T2 (de) Indolderivate als 5-ht rezeptorantagoniste
DE69617019D1 (de) Fluorinierte alkenyltriazine und ihre verwendung als vernetzungsmittel
DE69818248D1 (de) Chinolin- und chinazolin-derivate als crf antagonisten
DE69618959D1 (de) Pyrimidone und ihre verwendug als fungizide
ATE227266T1 (de) Aromatische c16-c20-substituierte tetrahydro- prostaglandine und ihre verwendung als prostaglandin f agonisten
DE69727565D1 (de) Isoxazol-derivate und ihre verwendung als herbizide
DE69608551T2 (de) Bicyclische amin-derivate und ihre verwendung als antipsychotische wirkstoffe
DE69613805D1 (de) Diiminoquinonderivate und ihre Verwendung als Elektronübertragungsmittel
ATE221529T1 (de) Oxadiazolinderivate und ihre verwendung als insektizide
ATE253059T1 (de) Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer
DE69408674D1 (de) Phenylpyrrol-derivate und ihre verwendung als dopamin d3 antagonisten
DE59806523D1 (de) Substituierte heterocyclische Benzocycloalkene und ihre Verwendung als analgetisch wirksame Substanzen
ATE210660T1 (de) Pyrazol-4-yl-benzoylderivate und ihre verwendung als herbizide
DE69831427D1 (de) Benzo(c)quinolizinderivative und deren verwendung als 5 alpha-reduktase-hemmer
DE59711502D1 (de) Oximderivate und ihre verwendung als fungizide
DE59610382D1 (de) Halogenbenzimidazole und ihre verwendung als mikrobizide
DE60008539D1 (de) Substituierte isochinolinderivate und ihre verwendung als anticonvulsiva
DE69412083D1 (de) Phenylpyrrolderivate und ihre verwendung als antipsychotika
DE69718850T2 (de) Heterocyclische N-Acetonylbenzamide und ihre Verwendung als Fungizide
DE69607578D1 (de) Diiminoquinonderivate und ihre Verwendung als Elektronübertragungsmittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition